ARC Future Fellowships - Grant ID: FT140101287

Funding Activity

Website
http://dataportal.arc.gov.au/NCGP/Web/Grant/Grant/FT140101287

Funding Status
Closed

Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the .

Funded Activity Summary

Alphaherpesvirus vaccination, recombination and latency; a study in the natural host. Attenuated alphaherpesvirus vaccines are used widely in production and companion animals to help control disease. These vaccines help to prevent clinical signs of disease following challenge with virulent viruses. There is also the potential to use these vaccines to help prevent latent herpesvirus infections, and to limit the opportunities for herpesvirus recombination to occur. This would enhance the ability to control disease in animal populations. This project aims to systematically study how vaccines may be used to limit latency and recombination events by studying avian infectious laryngotracheitis virus in the natural host leading to new insights into how vaccines may be used more efficaciously.

Funded Activity Details

Start Date: 30-06-2015

End Date: 31-12-2019

Funding Scheme: ARC Future Fellowships

Funding Amount: $772,104.00

Funder: Australian Research Council

Research Topics

ANZSRC Field of Research (FoR)

Veterinary Sciences | Veterinary Medicine | Veterinary Virology

ANZSRC Socio-Economic Objective (SEO)

Poultry | Veterinary Biological Preventatives (e.g. Vaccines) |

Other Keywords

Poultry | Veterinary Biological Preventatives (e.g. Vaccines) | Veterinary Medicine | Veterinary Sciences | Veterinary Virology

Related Links